**Chapter 6**

*Depigmentation*

2010;**35**:215-216

phenol solution. Anais Brasileiros de Dermatologia. 2005;**80**:415-416

[26] Rao J, Fitzpatrick RE. Use of the Q-switched 755 nm alexandrite laser to treat recalcitrant pigment after depigmentation therapy for vitiligo. Dermatologic Surgery.

[27] Leong KW, Lee TC, Goh AS.

[28] Senel E, Seckin D. Imiquimodinduced vitiligo-like depigmentation. Indian Journal of Dermatology, Venereology and Leprology.

hypopigmentation in the skin. Cancer.

Imatinib mesylate causes

2004;**30**:1043-1045

2004;**100**:2486-2487

2007;**73**:422-423

Depigmentation therapy in vitiligo universalis with cryotherapy and 4-hydroxyanisole. Clinical and Experimental Dermatology.

[18] Di Nuzzo S, Masotti A.

[19] Boen M, Vanaman Wilson MJ, Wu DC, Goldman MP. Laser depigmentation in extensive vitiligo.

Dermatologic Surgery. 2018:1

[20] Halder RM, Taliaferro SJ. Vitiligo. In: Wolff K, Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Lefell DJ, editors. Fitzpatrick's Dermatology in General Medicine. 7th ed. Vol. 1. New York: McGraw Hill; 2008. p. 61622

[21] Zirvi TB, Costarelis G, Gelfand JM.

Vitiligo-like hypopigmentation associated with imiquimod treatment of genital warts. Journal of the American Academy of Dermatology.

[22] Kang HY, Park TJ, Jin SH. Imiquimod, a toll-like receptor 7 agonist, inhibits melanogenesis and proliferation of human melanocytes.

The Journal of Investigative Dermatology. 2009;**129**:243-246

[23] Kim CH, Ahn JH, Kang SU, Hwang HS, Lee MH, Pyun JH, et al. Imiquimod induces apoptosis of human melanocytes. Archives of Dermatological Research.

[24] Thissen M, Westerhof W. Laser treatment for further depigmentation in vitiligo. International Journal of

Dermatology. 1997;**36**:3868

Surgery. 2001;**27**:969-970

[25] Kim YJ, Chung BS, Choi KC. Depigmentation therapy with Q-switched ruby laser after tanning in vitiligo universalis. Dermatologic

2005;**52**:715-716

2010;**302**:301-306

**66**
